---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-006547"
form_type: "8-K"
ticker: "NKTX"
cik: "0001787400"
company_name: "Nkarta, Inc."
filed_at: "2022-04-28T23:59:59+00:00"
generated_at: "2026-06-26T03:33:35.379365+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nkarta completes $215.5M public offering of 15.3M shares at $15/sh

## Summary
- Sold 13.33M firm shares plus 2M option shares at $15.00/sh.
- Net proceeds ~$215.5M after underwriting discounts and expenses.
- Proceeds to fund NKX101, NKX019 clinical development, preclinical programs, and manufacturing.
- Underwriters: Cowen, SVB Securities, Evercore.

## SEC filing metadata
- accession: 0000950170-22-006547
- form_type: 8-K
- ticker: NKTX
- cik: 0001787400
- company_name: Nkarta, Inc.
- filed_at: 2022-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787400/000095017022006547/0000950170-22-006547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787400/000095017022006547/nktx-20220428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-006547
- JSON: https://secwatch.observer/filing/0000950170-22-006547.json
- Plain text: https://secwatch.observer/filing/0000950170-22-006547.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.